Abstract
Dactinomycin is an old drug with activity in some childhood cancers; it acts as an inhibitor of RNA polymerase I. Its activity in acute myeloid leukemia has not been thoroughly examined. However, it has induced remissions in some patients with treatment-refractory disease.
Cite
CITATION STYLE
APA
Falini, B., Brunetti, L., & Martelli, M. P. (2015). Dactinomycin in NPM1 -Mutated Acute Myeloid Leukemia. New England Journal of Medicine, 373(12), 1180–1182. https://doi.org/10.1056/nejmc1509584
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free